Global Renal Diseases Drug Market Size, Status and Forecast 2019-2025

Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Renal Diseases Drug Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 Chronic Kidney Disease (CKD) Drugs
  • 1.4.3 End-Stage Kidney Disease (ESRD) Drugs
• 1.5 Market by Application
  • 1.5.1 Global Renal Diseases Drug Market Share by Application (2019-2025)
  • 1.5.2 Hospitals
  • 1.5.3 Specialty Clinics
  • 1.5.4 Other
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Renal Diseases Drug Market Size
• 2.2 Renal Diseases Drug Growth Trends by Regions
  • 2.2.1 Renal Diseases Drug Market Size by Regions (2019-2025)
  • 2.2.2 Renal Diseases Drug Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players

• 3.1 Renal Diseases Drug Market Size by by Players
  • 3.1.1 Global Renal Diseases Drug Revenue by by Players (2014-2019)
  • 3.1.2 Global Renal Diseases Drug Revenue Market Share by by Players (2014-2019)
  • 3.1.3 Global Renal Diseases Drug Market Concentration Ratio (CR5 and HHI)
• 3.2 Renal Diseases Drug Key Players Head office and Area Served
• 3.3 Key Players Renal Diseases Drug Product/Solution/Service
• 3.4 Date of Enter into Renal Diseases Drug Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Renal Diseases Drug Market Size by Type (2014-2019)
• 4.2 Global Renal Diseases Drug Market Size by Application (2014-2019)

5 North America

• 5.1 North America Renal Diseases Drug Market Size (2014-2019)
• 5.2 Renal Diseases Drug Key Players in North America
• 5.3 North America Renal Diseases Drug Market Size by Type
• 5.4 North America Renal Diseases Drug Market Size by Application

6 Europe

• 6.1 Europe Renal Diseases Drug Market Size (2014-2019)
• 6.2 Renal Diseases Drug Key Players in Europe
• 6.3 Europe Renal Diseases Drug Market Size by Type
• 6.4 Europe Renal Diseases Drug Market Size by Application

7 China

• 7.1 China Renal Diseases Drug Market Size (2014-2019)
• 7.2 Renal Diseases Drug Key Players in China
• 7.3 China Renal Diseases Drug Market Size by Type
• 7.4 China Renal Diseases Drug Market Size by Application

8 Japan

• 8.1 Japan Renal Diseases Drug Market Size (2014-2019)
• 8.2 Renal Diseases Drug Key Players in Japan
• 8.3 Japan Renal Diseases Drug Market Size by Type
• 8.4 Japan Renal Diseases Drug Market Size by Application

9 International Players Profiles

• 9.1 Pfizer
  • 9.1.1 Pfizer Company Details
  • 9.1.2 Company Description and Business Overview
  • 9.1.3 Renal Diseases Drug Introduction
  • 9.1.4 Pfizer Revenue in Renal Diseases Drug Business (2014-2019))
  • 9.1.5 Pfizer Recent Development
• 9.2 Amgen
  • 9.2.1 Amgen Company Details
  • 9.2.2 Company Description and Business Overview
  • 9.2.3 Renal Diseases Drug Introduction
  • 9.2.4 Amgen Revenue in Renal Diseases Drug Business (2014-2019)
  • 9.2.5 Amgen Recent Development
• 9.3 Roche
  • 9.3.1 Roche Company Details
  • 9.3.2 Company Description and Business Overview
  • 9.3.3 Renal Diseases Drug Introduction
  • 9.3.4 Roche Revenue in Renal Diseases Drug Business (2014-2019)
  • 9.3.5 Roche Recent Development
• 9.4 GlaxoSmithKline (GSK)
  • 9.4.1 GlaxoSmithKline (GSK) Company Details
  • 9.4.2 Company Description and Business Overview
  • 9.4.3 Renal Diseases Drug Introduction
  • 9.4.4 GlaxoSmithKline (GSK) Revenue in Renal Diseases Drug Business (2014-2019)
  • 9.4.5 GlaxoSmithKline (GSK) Recent Development
• 9.5 Allergan
  • 9.5.1 Allergan Company Details
  • 9.5.2 Company Description and Business Overview
  • 9.5.3 Renal Diseases Drug Introduction
  • 9.5.4 Allergan Revenue in Renal Diseases Drug Business (2014-2019)
  • 9.5.5 Allergan Recent Development
• 9.6 AbbVie
  • 9.6.1 AbbVie Company Details
  • 9.6.2 Company Description and Business Overview
  • 9.6.3 Renal Diseases Drug Introduction
  • 9.6.4 AbbVie Revenue in Renal Diseases Drug Business (2014-2019)
  • 9.6.5 AbbVie Recent Development
• 9.7 Kissei Pharmaceutical
  • 9.7.1 Kissei Pharmaceutical Company Details
  • 9.7.2 Company Description and Business Overview
  • 9.7.3 Renal Diseases Drug Introduction
  • 9.7.4 Kissei Pharmaceutical Revenue in Renal Diseases Drug Business (2014-2019)
  • 9.7.5 Kissei Pharmaceutical Recent Development
• 9.8 AstraZeneca
  • 9.8.1 AstraZeneca Company Details
  • 9.8.2 Company Description and Business Overview
  • 9.8.3 Renal Diseases Drug Introduction
  • 9.8.4 AstraZeneca Revenue in Renal Diseases Drug Business (2014-2019)
  • 9.8.5 AstraZeneca Recent Development
• 9.9 FibroGen
  • 9.9.1 FibroGen Company Details
  • 9.9.2 Company Description and Business Overview
  • 9.9.3 Renal Diseases Drug Introduction
  • 9.9.4 FibroGen Revenue in Renal Diseases Drug Business (2014-2019)
  • 9.9.5 FibroGen Recent Development
• 9.10 Sanofi
  • 9.10.1 Sanofi Company Details
  • 9.10.2 Company Description and Business Overview
  • 9.10.3 Renal Diseases Drug Introduction
  • 9.10.4 Sanofi Revenue in Renal Diseases Drug Business (2014-2019)
  • 9.10.5 Sanofi Recent Development
• 9.11 Teva Pharmaceutical Industries
• 9.12 Johnson & Johnson
• 9.13 Keryx Biopharmaceuticals

10 Market Forecast 2019-2025

• 10.1 Market Size Forecast by Product (2019-2025)
• 10.2 Market Size Forecast by Application (2019-2025)
• 10.3 Market Size Forecast by Regions
• 10.4 North America
• 10.5 Europe
• 10.6 China
• 10.7 Japan

11 Analyst's Viewpoints/Conclusions

12 Appendix

• 12.1 Research Methodology
  • 12.1.1 Methodology/Research Approach
    • 12.1.1.1 Research Programs/Design
    • 12.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 12.1.2 Data Source
    • 12.1.2.1 Secondary Sources
    • 12.1.2.2 Primary Sources
• 12.2 Disclaimer